[{"id":"69c0c3d7-d12e-4846-a87b-98d5f38f2dcd","acronym":"SJDAWN","url":"https://clinicaltrials.gov/study/NCT03434262","created_at":"2021-01-18T16:56:26.116Z","updated_at":"2025-02-25T15:54:00.489Z","phase":"Phase 1","brief_title":"SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors","source_id_and_acronym":"NCT03434262 - SJDAWN","lead_sponsor":"St. Jude Children's Research Hospital","biomarkers":" PTCH1","pipe":" | ","alterations":" PTCH1 mutation","tags":["PTCH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PTCH1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Mekinist (trametinib) • gemcitabine • Kisqali (ribociclib) • Odomzo (sonidegib) • Neupogen (filgrastim)"],"overall_status":"Completed","enrollment":" Enrollment 68","initiation":"Initiation: 03/05/2018","start_date":" 03/05/2018","primary_txt":" Primary completion: 09/30/2022","primary_completion_date":" 09/30/2022","study_txt":" Completion: 05/24/2024","study_completion_date":" 05/24/2024","last_update_posted":"2024-05-31"},{"id":"54f7cf2a-e22f-4512-a1d4-4bc3878de998","acronym":"","url":"https://clinicaltrials.gov/study/NCT04065776","created_at":"2021-01-18T19:55:12.604Z","updated_at":"2024-07-02T16:35:26.444Z","phase":"","brief_title":"Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma","source_id_and_acronym":"NCT04065776","lead_sponsor":"St. Jude Children's Research Hospital","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"],"overall_status":"Recruiting","enrollment":" Enrollment 74","initiation":"Initiation: 08/28/2019","start_date":" 08/28/2019","primary_txt":" Primary completion: 07/01/2027","primary_completion_date":" 07/01/2027","study_txt":" Completion: 07/01/2028","study_completion_date":" 07/01/2028","last_update_posted":"2023-12-12"},{"id":"c80eeae2-933f-4349-b377-8932b9e3ffc9","acronym":"rQNestin","url":"https://clinicaltrials.gov/study/NCT03152318","created_at":"2022-10-22T19:05:45.181Z","updated_at":"2024-07-02T16:35:40.606Z","phase":"Phase 1","brief_title":"A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2","source_id_and_acronym":"NCT03152318 - rQNestin","lead_sponsor":"Dana-Farber Cancer Institute","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation • IDH1 R132H • IDH wild-type • IDH1 R132","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation • IDH1 R132H • IDH wild-type • IDH1 R132"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • linoserpaturev (CAN-3110)"],"overall_status":"Recruiting","enrollment":" Enrollment 62","initiation":"Initiation: 07/18/2017","start_date":" 07/18/2017","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-08-08"},{"id":"18b3ff41-7240-462e-a0c8-23d7cea73e9b","acronym":"DIA/DIG","url":"https://clinicaltrials.gov/study/NCT03115164","created_at":"2021-01-18T15:20:38.794Z","updated_at":"2024-07-02T16:37:23.404Z","phase":"","brief_title":"Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics","source_id_and_acronym":"NCT03115164 - DIA/DIG","lead_sponsor":"Centre Hospitalier Universitaire, Amiens","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"],"overall_status":"Unknown status","enrollment":" Enrollment 30","initiation":"Initiation: 08/18/2016","start_date":" 08/18/2016","primary_txt":" Primary completion: 08/18/2017","primary_completion_date":" 08/18/2017","study_txt":" Completion: 08/18/2017","study_completion_date":" 08/18/2017","last_update_posted":"2017-04-14"}]